Components of mRNA Technology “Could Lead to Significant Adverse Events in One or More of Our Clinical Trials,” says Moderna

By the Children's Health Defense Team

A dozen Covid-19 vaccines are undergoing clinical trials and several of the U.S. contenders—Moderna, Pfizer/BioNTech and Arcturus Therapeutics—are deploying never-before-approved messenger RNA (mRNA) technology, an experimental approach designed to turn the body’s cells into viral-protein-making factories. This technology relies on a nanoparticle-based “carrier system” containing a synthetic chemical called polyethylene glycol (PEG). 

A 2016 study found roughly 70% of Americans may already be sensitized to PEG and investigators who once assumed that the polymer was largely “inert” are warning about adverse immune responses that include “probably underdiagnosed” life-threatening anaphylaxis (also called hypersensitivity). FDA approval of an mRNA vaccine for Covid-19 could be potentially disastrous. 

Moderna documents and publications indicate that the company is well aware of these safety risks but is more concerned with its bottom line.

Dr. Fauci’s Double Standards: Polarizing the Nation on Hydroxychloroquine

By Robert F. Kennedy, Jr., Chairman, Children’s Health Defense

On one hand, there’s Hydroxychloroquine (HCQ). Been in use 60+ years, patent is long expired…pills cost 30 cents and reportedly its relative, chloroquine is effective in preventing the spread of SARS CoV in cell culture. On the other hand, there’s vaccines (including the Moderna vaccine for which Dr. Fauci’s agency owns half the patent and has invested $500 million in taxpayer dollars.) Developed at a blistering pace, with limited testing and no manufacturer's liability.

I don’t know if hydroxychloroquine (HCQ) is effective against COVID, but it’s disturbing that I, like many other Americans, feel that we won’t learn the truth from Dr. Fauci.